Home / Inspections / 945407

FDA Inspection 945407 — Valgene Incorporated dba Cape Drugs

Valgene Incorporated dba Cape Drugs — FEI 3004562873

The FDA completed an inspection of Valgene Incorporated dba Cape Drugs on October 7, 2015 in Annapolis, MD. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
October 7, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Annapolis, MD (United States)

Facility

Other inspections at this facility

  • 1159287 (VAI Thu Dec 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1038474 (VAI Mon Jan 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources